AstraZeneca's revenue from Nexium by region 2018-2023
This statistic describes AstraZeneca's revenue from one of its top products, Nexium, by region from 2018 to 2023. In 2023, the regional revenue of Nexium was the highest in emerging markets, with some 578 million U.S. dollars. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. AstraZeneca is focused on products for the following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.